Your browser doesn't support javascript.
loading
Follistatin secretion is enhanced by protein, but not glucose or fat ingestion, in obese persons independently of previous gastric bypass surgery.
Bojsen-Møller, Kirstine N; Svane, Maria S; Jensen, Christian Z; Kjeldsen, Sasha A S; Holst, Jens J; Wewer Albrechtsen, Nicolai J; Madsbad, Sten.
Afiliação
  • Bojsen-Møller KN; Department of Endocrinology, Hvidovre Hospital, Copenhagen, Denmark.
  • Svane MS; Novo Nordic Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Jensen CZ; Department of Endocrinology, Hvidovre Hospital, Copenhagen, Denmark.
  • Kjeldsen SAS; Novo Nordic Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Holst JJ; Department of Endocrinology, Hvidovre Hospital, Copenhagen, Denmark.
  • Wewer Albrechtsen NJ; Novo Nordic Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Madsbad S; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Am J Physiol Gastrointest Liver Physiol ; 320(5): G753-G758, 2021 05 01.
Article em En | MEDLINE | ID: mdl-33655762
ABSTRACT
Follistatin is secreted from the liver and is involved in the regulation of muscle mass and insulin sensitivity via inhibition of activin A in humans. The secretion of follistatin seems to be stimulated by glucagon and inhibited by insulin, but only limited knowledge on the postprandial regulation of follistatin exists. Moreover, results on postoperative changes after Roux-en-Y gastric bypass (RYGB) are conflicting with reports of increased, unaltered, and lowered fasting concentrations of follistatin. In this study, we investigated postprandial follistatin and activin A concentrations after intake of isocaloric amounts of protein, fat, or glucose in subjects with obesity with and without previous RYGB to explore the regulation of follistatin by the individual macronutrients. Protein intake enhanced follistatin concentrations similarly in the two groups, whereas glucose and fat ingestion did not change postprandial follistatin concentrations. Concentrations of activin A were lower after protein intake compared with glucose intake in RYGB. Glucagon concentrations were also particularly enhanced by protein intake and tended to correlate with follistatin in RYGB. In conclusion, we demonstrated that protein intake, but not glucose or fat, is a strong stimulus for follistatin secretion in subjects with obesity and that this regulation is maintained after RYGB surgery.NEW & NOTEWORTHY Circulating follistatin and activin A were studied after intake of isocaloric protein, fat, or glucose drinks in subjects with obesity with and without previous Roux-en-Y gastric bypass (RYGB). Protein intake enhanced follistatin similarly in both groups, whereas glucose and fat ingestion did not change follistatin. Activin A was lower after protein compared with glucose in RYGB. The novel finding is that protein intake, but neither glucose nor fat, stimulates follistatin secretion independently of previous RYGB.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Gorduras na Dieta / Proteínas Alimentares / Derivação Gástrica / Folistatina / Glucose / Obesidade Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Gorduras na Dieta / Proteínas Alimentares / Derivação Gástrica / Folistatina / Glucose / Obesidade Idioma: En Ano de publicação: 2021 Tipo de documento: Article